Carilex Medical (ROCO:7726) Beginning Cash Position: NT$224.3 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7726 Carilex Medical Inc ROCO:7726
42 GF Score
Price NT$32.15
! 5 Warning Signs
View Full Analysis

What is Carilex Medical Beginning Cash Position?

Carilex Medical ROCO:7726 42 Beginning Cash Position is NT$224.3 Mil as of Jun. 2026. GuruFocus rates ROCO:7726 with a GF Score™ of 42/100. The stock has 5 warning signs investors should review.

Carilex Medical's Beginning Cash Position for the quarter that ended in Jun. 2026 was NT$224.3 Mil.

Carilex Medical's quarterly Beginning Cash Position increased from Jun. 2025 (NT$137.1 Mil) to Dec. 2025 (NT$160.2 Mil) and increased from Dec. 2025 (NT$160.2 Mil) to Jun. 2026 (NT$224.3 Mil).

Carilex Medical's annual Beginning Cash Position increased from Dec. 2023 (NT$129.4 Mil) to Dec. 2024 (NT$173.2 Mil) but then declined from Dec. 2024 (NT$173.2 Mil) to Dec. 2025 (NT$137.1 Mil).

Carilex Medical Beginning Cash Position Related Terms

Carilex Medical Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Carilex Medical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carilex Medical Beginning Cash Position Chart

Carilex Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 105.05 138.94 129.41 173.16 137.10

Carilex Medical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 173.16 192.23 137.10 160.21 224.27
ROCO:7726
42GF Score
Carilex Medical Inc ROCO:7726
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carilex Medical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of NT$224.3 Mil mean?
Carilex Medical (ROCO:7726) has a Beginning Cash Position of NT$224.3 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Carilex Medical and its competitors.
Is Carilex Medical's Beginning Cash Position too high?
Carilex Medical's current Beginning Cash Position is NT$224.3 Mil. Overall, Carilex Medical has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Carilex Medical's Beginning Cash Position compare to ABT and SYK?
Carilex Medical's Beginning Cash Position of NT$224.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Carilex Medical and its competitors. Carilex Medical's current Beginning Cash Position is NT$224.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carilex Medical stock overvalued right now?
Carilex Medical (ROCO:7726) has a current Beginning Cash Position of NT$224.3 Mil. The current Beginning Cash Position is NT$224.3 Mil. Carilex Medical's overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Carilex Medical (ROCO:7726), the current Beginning Cash Position is NT$224.3 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Carilex Medical Business Description

Address No.77, Keji 1st Road, Guishan District, Taoyuan, TWN, 33383
Carilex Medical Inc is a company engaged in the wound care industry by developing leading-edge technology in the prevention and treatment of wounds. Their expertise is in research and development, manufacturing, and quality control and assurance allow us to provide unparalleled products in wound care management in the form of comprehensive product lines proven to prevent and manage pressure sores and wounds. They offer products in the form of Support Surfaces, Chair Cushion and Negative Pressure Wound Therapy.
42GF Score

Get the complete analysis for ROCO:7726

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$32.15
Price